Top Analyst Upgrades and Downgrades: AutoZone, Glaukos, Itron, Leidos, Lowe’s, Salesforce, Shopify, Toyota and More

Print Email

The stock market has seen its first monthly drop in some time, with the Dow Jones industrial average losing about 4% in February. Stocks were indicated lower on Thursday ahead of Federal Reserve Chair Jerome Powell’s second testimony on Thursday. That being said, the trend that has worked well is for investors to buy the dips. And this bull market is now a week short of being nine years old. Investors are having to decide how they want to be positioned for the rest of 2018 and beyond.

24/7 Wall St. reviews dozens of analyst research reports each day of the week to find new ideas for investors and traders alike. Some analyst and research reports cover stocks to buy. Others cover stocks to sell or to avoid.

Additional color and commentary has been added on most of the daily analyst reports. The consensus analyst price targets and other valuation metrics are from the Thomson Reuters sell-side research service.

These were the top analyst upgrades, downgrades and other research calls from Thursday, March 1, 2018.

American Assets Trust Inc. (NYSE: AAT) was downgraded to Underperform from Neutral and the price objective was lowered to $35 from $37 (versus a $31.72 prior close) at Merrill Lynch.

AutoZone Inc. (NYSE: AZO) was maintained as Buy but the target price was cut to $790 from $820 (versus a $664.72 close) at Citigroup.

Carrizo Oil & Gas Inc. (NASDAQ: CRZO) was raised to Buy from Hold with a $20 price target (versus a $14.05 close) at Jefferies.

Clean Harbors Inc. (NYSE: CLH) was downgraded to Perform from Outperform at Oppenheimer.

Cross Country Healthcare Inc. (NASDAQ: CCRN) was downgraded to Hold from Buy at Benchmark.

Entertainment Properties Trust (NYSE: EPR) was downgraded to Sector Weight from Overweight at KeyBanc Capital Markets.

Gibraltar Industries Inc. (NASDAQ: ROCK) was downgraded to Sector Weight from Overweight at KeyBanc Capital Markets.

Glaukos Corp. (NASDAQ: GKOS) was maintained as Buy but the price target was cut to $43 from $48 (versus a $31.30 close) at Canaccord Genuity.

Health Insurance Innovations Inc. (NASDAQ: HIIQ) was raised to Outperform from Market Perform at Raymond James. Its shares were last seen up 10.9% at $34.60 after beating earnings expectations.

Follow @Jonogg on Twitter to receive the daily analyst calls and other market research calls directly on your feed.